Literature DB >> 24072762

Meningoencephalitis due to Gemella haemolysans.

Benjamin T Galen1, David B Banach2, Melissa R Gitman3, Terence K Trow4.   

Abstract

Gemella haemolysans is an uncommon but described cause of invasive disease in humans. We report a case of meningitis due to G. haemolysans that did not grow in cerebrospinal fluid culture, demonstrating a potential role for direct 16S rRNA gene PCR and sequencing in culture-negative cerebrospinal fluid when bacterial meningitis is suspected.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24072762     DOI: 10.1099/jmm.0.063347-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Unreported neurological complications of Gemella bergeriae infective endocarditis.

Authors:  Kosar Hussain; Jawed Abubaker; Zulfa Omar Al Deesi; Raees Ahmed
Journal:  BMJ Case Rep       Date:  2014-06-04

2.  Phylogenetic and syntenic data support a single horizontal transference to a Trypanosoma ancestor of a prokaryotic proline racemase implicated in parasite evasion from host defences.

Authors:  Zuleima C Caballero; Andre G Costa-Martins; Robson C Ferreira; João M P Alves; Myrna G Serrano; Erney P Camargo; Gregory A Buck; Paola Minoprio; Marta M G Teixeira
Journal:  Parasit Vectors       Date:  2015-04-12       Impact factor: 3.876

3.  Gemella haemolysans bacteremia in a patient with secondary peritonitis due to a duodenal ulcer perforation: A case report.

Authors:  Yoshiro Hadano; Yusuke Kinugasa; Kiyofumi Ohkusu; Kazushige Ishibashi; Miwako Isoda
Journal:  IDCases       Date:  2018-05-01

4.  A Case Report of Gemella haemolysans Keratitis After Refractive Surgery.

Authors:  Yaohua Zhai; Chenjiu Pang; Shengtao Sun; Qiufei Ma; Lei Han; Yuwei Gu; Lizhe Gu
Journal:  Infect Drug Resist       Date:  2021-12-06       Impact factor: 4.003

5.  [Post-surgical meningitis by Gemella haemolysans].

Authors:  M Domínguez-Gil; J M Eiros; C Klein; J Herrero; L Pastor; R Sarabia
Journal:  Rev Esp Quimioter       Date:  2018-02-08       Impact factor: 1.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.